1. Home
  2. HMN vs VERA Comparison

HMN vs VERA Comparison

Compare HMN & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horace Mann Educators Corporation

HMN

Horace Mann Educators Corporation

HOLD

Current Price

$42.53

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$46.59

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HMN
VERA
Founded
1945
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.5B
IPO Year
1991
2021

Fundamental Metrics

Financial Performance
Metric
HMN
VERA
Price
$42.53
$46.59
Analyst Decision
Buy
Strong Buy
Analyst Count
5
11
Target Price
$46.75
$76.60
AVG Volume (30 Days)
233.6K
1.1M
Earning Date
02-03-2026
02-25-2026
Dividend Yield
3.30%
N/A
EPS Growth
56.80
N/A
EPS
3.95
N/A
Revenue
$1,675,600,000.00
N/A
Revenue This Year
$7.70
N/A
Revenue Next Year
$6.46
N/A
P/E Ratio
$10.75
N/A
Revenue Growth
5.44
N/A
52 Week Low
$37.21
$18.53
52 Week High
$48.33
$56.05

Technical Indicators

Market Signals
Indicator
HMN
VERA
Relative Strength Index (RSI) 29.16 50.00
Support Level $44.18 $45.02
Resistance Level $46.19 $49.75
Average True Range (ATR) 1.06 2.51
MACD -0.38 -0.98
Stochastic Oscillator 6.75 18.54

Price Performance

Historical Comparison
HMN
VERA

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are 403(b) tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: